Metabolic syndrome and non-alcoholic fatty liver disease after liver or kidney transplantation (Q38682089)

5 September 2017

Metabolic syndrome and non-alcoholic fatty liver disease after liver or kidney transplantation (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

5 September 2017

1 reference

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

1 reference

Ivana Mikolasevic

1

1 reference

5 September 2017

Lidija Orlic

series ordinal

2

1 reference

5 September 2017

Irena Hrstic

series ordinal

3

1 reference

5 September 2017

Sandra Milic

series ordinal

4

1 reference

5 September 2017

language of work or name

1 reference

29 December 2015

1 reference

5 September 2017

1 reference

5 September 2017

46

1 reference

5 September 2017

841-852

1 reference

5 September 2017

9

1 reference

Evolving frequency and outcomes of simultaneous liver kidney transplants based on liver disease etiology

5 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Cumulative risk of cardiovascular events after orthotopic liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Metabolic syndrome after liver transplantation: preventable illness or common consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Cyclosporin versus tacrolimus for liver transplanted patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Posttransplant metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

CKD and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Prevention of cardiovascular disease in adult recipients of kidney transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Metabolic syndrome in kidney transplantation: management of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Metabolic syndrome, insulin resistance, and chronic allograft dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Insulin resistance as putative cause of chronic renal transplant dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Obesity and outcome following renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Posttransplant metabolic syndrome: an epidemic waiting to happen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

De novo nonalcoholic fatty liver disease after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Metabolic syndrome in liver transplant recipients: prevalence and association with major vascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Metabolic syndrome and liver transplantation: a review and guide to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Transplanted liver: consequences of denervation for liver functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Metabolic syndrome and its components after liver transplantation: incidence, prevalence, risk factors, and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Changes in nutritional status after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

De Novo Non-Alcoholic Fatty Liver Disease Following Orthotopic Liver Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Independent risk factors and natural history of renal dysfunction in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Nonalcoholic fatty liver disease and liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Adipobiology of disease: adipokines and adipokine-targeted pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Extrahepatic complications of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Increased risk of cardiovascular disease and chronic kidney disease in NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Liver transplantation for nonalcoholic fatty liver disease: new challenges and new opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Chronic kidney disease (CKD) and NAFLD: time for awareness and screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Chronic renal failure after transplantation of a nonrenal organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Patient-specific prediction of ESRD after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

The variable pathology of kidney disease after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Renal histopathological lesions after orthotopic liver transplantation (OLT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: Time to reconsider immunosuppression regimens?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Markers of the hepatic component of the metabolic syndrome as predictors of mortality in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Glomerular hyperfiltration: a new marker of metabolic risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Hyperinsulinemia and hyperfiltration in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

The role of oxidative stress in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Chronic kidney disease and nonalcoholic Fatty liver disease-is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Metabolic syndrome, vitamin D deficiency and hypoadiponectinemia among nondiabetic patients early after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Vitamin D levels and liver histological alterations in children with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Vitamin D status in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12642

21 January 2018

Identifiers

DOI

10.1111/HEPR.12642

1 reference

5 September 2017

1 reference